Health Catalyst
NasdaqGS:HCAT
$ 1,23
+ $0,01 (0,82%)
1,23 $
+$0,01 (0,82%)
End-of-day quote: 03/20/2026

Health Catalyst Stock Value

Analysts currently rate NasdaqGS:HCAT as Hold.
Hold
Hold

Health Catalyst Company Info

EPS Growth 5Y
18,14%
Market Cap
$0,09 B
Long-Term Debt
$0,15 B
Short Interest
5,06%
Quarterly earnings
05/07/2026 (E)
Dividend
$0,00
Dividend Yield
0,00%
Founded
2008
Industry
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$2,00
62.6%
62.6
Last Update: 03/22/2026
Analysts: 8

Highest Price Target $3,00

Average Price Target $2,00

Lowest Price Target $1,00

In the last five quarters, Health Catalyst’s Price Target has fallen from $51,45 to $9,79 - a -80,97% decrease. Seven analysts predict that Health Catalyst’s share price will increase in the coming year, reaching $2,00. This would represent an increase of 62,60%.

Top growth stocks in the health care sector (5Y.)

What does Health Catalyst do?

Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The company’s Solution comprises its cloud-based data and analytics platform, software applications, and expertise. The company’s clients, which are primarily healthcare providers, use the company’s Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements. The core elements of the...
×